Human chorionic gonadotropin increases β-cleavage of amyloid precursor protein in SH-SY5Y cells

Cellular and Molecular Neurobiology

Volumn 33, Issue 6, 2013, Pages 747-751

  Saberi, Soheila ^a   Du, Yan Ping ^a   Christie, Macdonald ^a   Goldsbury, Claire ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alzheimer's disease (AD); Amyloid precursor protein (APP); Human chorionic gonadotropin (hCG); Luteinizing hormone receptor (LHR)

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; AMYLOID PRECURSOR PROTEIN; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA;

ALZHEIMER DISEASE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SENILE PLAQUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEUROBLASTOMA; TUMOR CELL LINE;

AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE, TUMOR; CHORIONIC GONADOTROPIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; RECEPTORS, LH; RNA, MESSENGER;

EID: 84881096448     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9954-3     Document Type: Article

References (16)

1. Apaja PM, Harju KT, Aatsinki JT, Petäjä-Repo UE, Rajaniemi HJ (2004) Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J Biol Chem 279:1899-1906
2. Barron AM, Verdile G, Taddei K, Bates KA, Martins RN (2010) Effect of Chronic hCG administration on Alzheimer's-related cognition and Aβ accumulation in PS1KI mice. Endocrinology 151:5380-5388
3. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS (2004) Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-β precursor protein and amyloid-β deposition. J Biol Chem 279(19):20539-20545
4. Casadesus G, Milliken EL, Webber KM, Bowen RL, Lei Z, Rao CV, Perry G, Keri RA, Smith MA (2007) Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol 269:107-111
5. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164:719-725
6. Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2:a006270. doi: 10.1101/cshperspect.a006270
7. Hicks DA, Nalivaeva NN, Turner AJ (2012) Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front Physiol 3:189
8. Holsinger RM, Lee JS, Boyd A, Masters CL, Collins SJ (2006) CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias. Neurology 67:710-712
9. Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES (1993) Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132(5):2262-2270
10. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L (2002) Incidence of AD may decline in the early 90s for men, later for women: the cache county study. Neurology 58(2):209-218
11. Porayette P, Gallego MJ, Kaltcheva MM, Meetal SV, Atwood CS (2007) Amyloid-β precursor protein and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin. Biochem Biophys Res Commun 364:522-527
12. Schupf N, Kapell D, Nightingale B, Rodriguez A, Tycko B, Mayeux R (1998) Earlier onset of Alzheimer's disease in men with down syndrome. Neurology 50:991-995
13. Short RA, Bowen RL, O'Brien PC, Graff-Radford NR (2001) Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 76:906-909
14. Wahjoepramono EJ, Wijaya LK, Taddei K, Bates KA, Howard M, Martins G, deRuyck K, Matthews PM, Verdile G, Martins RN (2011) Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels. Neuroendocrinology 94(4):313-322
15. Watanabe T, Hikichi Y, Willuweit A, Shintani Y, Horiguchi T (2012) FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis. J Neurosci 32(10):3352-3365
16. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the cache county study. JAMA 288(17):2123-2129